AUG 25, 2015 1:31 PM PDT

E. coli Infections Thwarted By Flu Treatments

WRITTEN BY: Kara Marker
The "gut microbiome" refers to the trillions of bacteria that colonize our intestines. The normal metabolic functions of these bacteria play an infinite role in human digestion, disease etiology, and other actions that have countless impacts on human health. The diversity of the bacteria in the human microbiome is incredibly vast, and the study of these gut flora has been one of recent interest and growth in the field of microbiology (Nature). Incredibly, there are more bacterial cells in our bodies than human cells.

Our gut microbiome, when regulated correctly, helps us with digestion and other processes.
Escherichia coli is a well-known bacteria common in cases of food-poisoning, but it is also a normal contributor to the gut microbiota. Under normal conditions, the body regulates the amount of different bacteria colonies that thrive in the gut. Under a proper balance, E. coli can live in our intestines without causing disease. A recent study at the University of Zurich described what happens when the microbiota equilibrium is disturbed. Although sometimes unexplained, damage to the intestines can cause certain bacterial groups, like E. coli, to grow to larger numbers than usual and cause infection-related inflammation in the gut. Misuse of antibiotics is often a known cause of these type of intestinal infections. When normal, harmless gut microbiota is killed after an unnecessary or overboard dose of antibiotics, bacteria like E. coli are left without bacterial neighbors competing for space and nutrients. Then, E. coli colonies grow to even larger numbers and cause disease.  

The researchers from Zurich found that "overproduction of E. coli can be attributed to the availability of the carbohydrate sialic acid." Surprisingly, E. coli doesn't make the enzyme needed to utilize sialic acid, sialidase. The bacteria find sialidase to use when its produced by other intestinal bacteria.

It turns out that treatments developed to combat flu infections contain a sialidase inhibitor. So patients with a microbiota imbalance will less often suffer from E. coli infections when they're already being treated with a flu remedy, like Tamiflu. The researchers are excited about the "new therapeutic possibilities" that could be derived from the components of flu medicines. New treatments for inflammatory intestinal diseases could be developing very soon.

In the video below, listen and watch NPR explain further the relationship between a human and his/her microbiome. 



Source: University of Zurich Media Desk 


 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
MAR 18, 2020
Earth & The Environment
MAR 18, 2020
Why Are Nanoplastics so Hard to Get Out of Water?
By now, you’ve probably heard of microplastics, which have infiltrated the environment from the deepest parts of the sea to remote mountain ranges. R
MAR 24, 2020
Drug Discovery & Development
MAR 24, 2020
How Will the Coronavirus Change Drug Development?
Cataclysmic bombshells to society- be they actual bombshells by means of war, or metaphorical ones by natural catastrophe or financial collapse, tend to la
MAR 23, 2020
Chemistry & Physics
MAR 23, 2020
Is it possible to degrade PFASs?
Have you ever heard of PFASs? Also known as per- and polyfluoroalkyl substances, these synthetic chemicals built of carbon and fluorine atoms have the most
MAR 26, 2020
Microbiology
MAR 26, 2020
US Now Leads the World in Coronavirus Cases
In the United States, there have been 83,836 confirmed cases of COVID-19, and over 529,000 worldwide.
APR 02, 2020
Immunology
APR 02, 2020
Potential New COVID-19 Vaccine is Delivered by Patch
The coronavirus pandemic caused by SARS-CoV-2 is demanding the world's immediate attention.
APR 09, 2020
Drug Discovery & Development
APR 09, 2020
Does Hydroxychloroquine Really Work Against COVID-19?
Although US President Donald Trump is a strong supporter of antimalarial drug Hydroxychloroquine as a treatment for COVID-19, there is currently no clinica
Loading Comments...